arrow
C

Christopher A. French

Brigham and Women's Hospital
H指数:52
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma

共靶向CDK2和CDK9抑制MYC致癌程序,并在CIC重排肉瘤中具有抗肿瘤作用

2026-10-070
OA
International guidelines on the diagnosis and treatment of NUT carcinoma

NUT癌的诊断与治疗国际指南

2025-07-310
OAAI
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer

血浆表观基因组分析揭示了前列腺癌中治疗相关的鳞状细胞转化。

2025-07-090
OAAI
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma
2023-10-117
OAAI
EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes
2023-09-253
OA
Report of the First International Symposium on NUT Carcinoma
2022-04-1328
OA
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study
2021-11-2650
OA
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE
2021-03-0117
OAAI
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
2020-12-1486
OAAI